Our kinetic analysis of METTL16 cancer-associated mutants identified one mutant, METTL16 R200Q, with increased catalytic efficiency (Table 5), which is consistent with this mutant showing enhanced methylation activity in previous cell-based assays [61]. The gene discussed is METTL16; the disease is cancer.